Simplex Trading »

Rapt Therapeutics shares owned by Simplex Trading

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Simplex Trading

Quarter filed Position value Share count Share price at filing
2025-12-31 $96k 2.8k 33.87
2025-06-30 $999 197 5.08

More positions owned by Simplex Trading

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Put Put Option
Invesco Qqq Tr Call Call Option
Tesla Put Put Option
Nvidia Corporation Call Call Option
Tesla Call Call Option
Nvidia Corporation Put Put Option
Ishares Tr Put Put Option
Meta Platforms Call Call Option
Alphabet Call Call Option
Ishares Tr Call Call Option
Spdr Gold Tr Call Call Option
Apple Call Call Option
Alphabet Put Put Option

View all positions for Simplex Trading

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics